CJC-1295/Ipamorelin
Also known as: CJC-1295 (no DAC) + Ipamorelin blend
A grey-market pre-mixed blend of CJC-1295 (no DAC / Modified GRF 1-29), a GHRH analog, and Ipamorelin, a selective ghrelin-receptor agonist. The blend itself is NOT clinically validated — no controlled human trial has tested this specific combination. The pharmacological rationale (GHRH + GHRP synergy for pulsatile GH amplification) is inferred from studies of other GHRH/GHRP pairs.
Who's worth your money for CJC-1295/Ipamorelin
Every current seller, ranked by independent evidence — Merit Score, latest COA purity, and live $/mg (size-normalized). Prices refresh daily. Rankings are never paid.
Top Merit pick
Highest Merit Score (89) of 2 scored sellers
$50.00 · 10mg
Best value
Lowest $/mg among scored sellers
$85.00 · 10mg · 99.9% purity
Average price
$6.77/mg
Sellers
77
45-day trend
-13.5%
61 of 77 sellers have a current price· 59 stale hidden
Top Merit pick
🇺🇸 Peptide Plugs89✓ verified at source · just now
$5.00/mg -26.1% vs avg$50.00
10mg
no purity- 🇺🇸 Blank Peptides81
✓ verified at source · just now
$8.50/mg +25.6% vs avg$85.00
10mg
Prices observed from public storefronts (last 24h), normalized to $/mg. "Evidence" is Merit's 0–100 Merit Score, derived only from observable verification evidence (methodology on /about); "Purity" is the latest independent COA. Some buy links are affiliate links — Merit may earn a commission at no extra cost to you, and where a vendor offers one, the code shown gets you a discount at their checkout. Affiliate status never affects price data, ranking, or the Merit Score (full policy on /disclosure). Research use only.
Watch CJC-1295/Ipamorelin
Get one email when the market actually moves — no newsletter, no noise.
About CJC-1295/Ipamorelin
CAS
—
Molecular formula
—
Typical dose range
100–300 mcg of each component (CJC-1295 no DAC + Ipamorelin) per injection, 1–2x daily subcutaneous, typically on empty stomach
Half-life
CJC-1295 (no DAC): ~30 minutes; Ipamorelin: ~2 hours
COAs for CJC-1295/Ipamorelin
82 third-party tests across 31 vendors. Each card links to the full report.
For
CJC-1295/Ipamorelin
by Rescue Research USA· batch RR-CJCIPA2607
For
CJC-1295/Ipamorelin
by OROS Research· batch OR-LPCJCIPA20-626-B3
For
CJC-1295/Ipamorelin
by Peptide Supply Co.· batch CI10 06032026
For
CJC-1295/Ipamorelin
by OROS Research· batch OR-LPCJCIPA10-526-B10
For
CJC-1295/Ipamorelin
by Secra Labs· batch SL-202605-CJCIPA
For
CJC-1295/Ipamorelin
by Modern Research Peptides· batch YCJLS2581
For
CJC-1295/Ipamorelin
by Modern Research Peptides· batch RCJLS3422
For
CJC-1295/Ipamorelin
by OROS Research· batch OR-LPCJCIPA10-526-B9
For
Ipamorelin/CJC-1295
by Sunrise Bioresearch· batch CP10MAY26-01
For
CJC/IPA
by Riptide Wellness· batch RWCP-10-1003
For
CJC / Ipamorelin
by NG Peptide· batch CJPA10-03
For
CJC-1295/Ipamorelin
by OROS Research· batch OR-LPCJCIPA10-326-B8
For
CJC-1295/Ipamorelin
by OROS Research· batch OR-LPCJCIPA20-326-B2
For
CJC-1295 (No DAC)/Ipamorelin
by Ion Peptide· batch CP10-04042026
For
Ipamorelin/CJC-1295
by Blank Peptides· batch 665394
For
CJC-1295 / Ipamorelin (No DAC)
by Amino Club· batch CIP0001
For
CJC-1295/Ipamorelin
by Crush Research· batch CR-CJIP20-2603-1
For
CJC-1295 (No DAC)/Ipamorelin
by Ion Peptide· batch CP10-03262026
For
CJC-1295 (No DAC)/Ipamorelin
by Ion Peptide· batch CP-10-03242026
For
CJC-1295 (No DAC)/Ipamorelin
by Mile High Compounds· batch CIB-010-MH-01
For
CJC-1295 (No DAC)/Ipamorelin
by Glacier Aminos· batch CJIP10GA-03
For
CJC-1295/Ipamorelin
by Peptidology· batch 1668
For
CJC-1295 + Ipamorelin (no dac)
by Nox Amino· batch NA-CP0226-01
For
CJC-1295/Ipamorelin
by Peptidology· batch 1669
5 citations indexed for CJC-1295/Ipamorelin
review · 2026
Injectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Implications
Background Injectable peptides are increasingly promoted for musculoskeletal recovery, tissue repair, and performance enhancements; however, clinical adoption has outpaced high-quality evidence and regulatory consensus.
review · 2026
Therapeutic peptides in gerontology: mechanisms and applications for healthy aging
Background Peptide therapeutics represent an emerging frontier in gerontological medicine, targeting fundamental hallmarks of aging including metabolic dysfunction, telomere attrition, tissue repair impairment, and hormonal decline.
review · 2026
Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians
Background Therapeutic peptides are short-chain amino acids that regulate cellular functions and facilitate biochemical processes. In recent years, there has been significant growth in the global market for therapeutic peptides and thus its popularity among patients.
review · 2026
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions
Therapeutic peptides are emerging as promising adjuncts in the management of orthopaedic injuries, grounded in their ability to modulate molecular signaling networks central to cellular medicine.
Study · 2022